Professor Robert Clarke
- Developing novel genetic risk scores for prediction of cardiovascular disease
- Causes and consequences of frailty in 0.5M adults living in China
- Patterns, determinants and prognosis of multi-morbidity associated with major cardiometabolic diseases in Chinese adults
- Prediction of cardiovascular disease in 0.5M adults living in the UK: evaluation of novel risk factors using modern statistical approaches
- Causes and consequences of frailty in older people in China
- Causes and consequences of heart failure in Chinese adults
MD, FRCP, FFPH, FFPHI, MSc, DCH
Professor of Epidemiology and Public Health Medicine
- Clinical Trial Service Unit and Epidemiological Studies Unit
Robert Clarke is a Professor of Epidemiology and Public Health Medicine at the Clinical Trial Service Unit (CTSU), Nuffield Department of Population Health, University of Oxford and Consultant in Public Health Medicine and Director of the MSc course in Global Health Science. He qualified in clinical medicine in Ireland and worked for 5 years in internal medicine and 4 years in cardiology. After 2 years in clinical pharmacology at Vanderbilt University, Nashville, USA, he joined CTSU in 1991 and specialised in Cardiovascular Epidemiology.
His main research interests are to understand the importance of classical and novel risk factors for occlusive vascular diseases. He led several large observational studies and meta-analyses of observational studies and randomized trials (eg, Whitehall study, PROCARDIS, CARDIoGRAMplusC4D, B-Vitamin Treatment Trialists’ Collaboration and the BEST-D trial). He also worked extensively on the Prospective Studies Collaboration and the China Kadoorie Biobank (CKB) study. He currently leads a research programme to assess the importance of blood pressure, blood lipids, and novel biomarkers (including genetic markers, cytokines, proteomics and metabolomics) for occlusive vascular diseases in the CKB study. His work has been widely cited (200 publications, H-index of 54) and is listed in Tomson Reuters’ Most Influential Scientific Minds 2014.
Cardiovascular risk factors and frailty in a cross-sectional study of older people: implications for prevention.
Wong TY. et al, (2018), Age Ageing, 47, 714 - 720
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
Clarke RJ. et al, (2018), JAMA Cardiol, 3, 781 - 782
Age-specific relation of blood pressure to vascular and non-vascular chronic disease in China: a prospective study of 0.5 million adults
Lacey BWH. et al, (2018), The Lancet Global Health
Adiposity and risk of ischaemic and haemorrhagic stroke in Chinese men and women: a prospective study of 0.5 million adults
Chen Z. et al, (2018), The Lancet Global Health
Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study.
Lacey B. et al, (2018), Lancet Glob Health, 6, e641 - e649